Lemaitre Vascular (LMAT) Tops Q1 EPS by 2c; Guides Above Consensus

Lemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $47.1 million versus the consensus estimate of $43.53 million.

GUIDANCE:

Lemaitre Vascular sees Q2 2023 EPS of $0.30-$0.35, versus the consensus of $0.31. Lemaitre Vascular sees Q2 2023 revenue of $47.1-49.5 million, versus the consensus of $44.94 million.

Lemaitre Vascular sees FY2023 EPS of $1.15-$1.28, versus the consensus of $1.16. Lemaitre Vascular sees FY2023 revenue of $187.1-193.1 million, versus the consensus of $176.11 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
• Hermes stock target lowered at Citi on continued China weakness
• Inogen to sell U.S. oxygen rental business to Rotech for up to $25M